Q3 2024 Earnings Call Transcript November 3, 2024 Operator: Good day, and welcome to the Kymera Therapeutics Third Quarter ...

In addition, we saw continued year-over-year growth for TAVALISSE and REZLIDHIA with both achieving another record quarter ...

Greetings and welcome to Rigel Pharmaceutical's Financial Conference Call for the Third Quarter 2024. At this time, all participants are in a listen-only mode. A brief question and answer session will ...

IND cleared by FDA and dosing in the Phase 1 clinical trial initiated, with data expected in the first half of 2025Sanofi ...

Good morning, and welcome to Y-mAbs Therapeutics Inc. Third Quarter Conference Call for 2024. At this time, all participants are in a listen-only mode. Instruction for the question-and-answer session ...

This semester's tour saw 14 faculty, staff and administrators from the college's various health and education programs travel to Pine Bluff, Monticello, Portland and El Dorado Oct. 23-25.

The Journal provides free space for parties on the referendum ballot. All statements are unedited. This year’s fall referendum—and Undergraduate Trustee Election—will take place on Oct. 30 to 31.

Preclinical proof-of-concept data supports the potential of CD3 Switch-DARPin platform to activate and boost T cells in the presence of tumor ...

Zale Peart ’25 presents his poster, “Rethinking Rail ... “After graduation, I am hoping to go into some form of art administration work or communication design. My research in the Creativity Pathway ...

BERKELEY, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today reported financial results ...